The Project Sessions
The Clinical PM of the future
The third of our Project Sessions' series, will ask this question...
How has COVID-19 impacted the way we do Clinical Trials?
Keynote speaker, Shola Ayeni from Applied Molecular Transport will present the operational impact of COVID-19 on Clinical Trials, including:
- The impact on study set-up
- The changes to study conduct
The need for innovation
The session will also feature an interactive breakout session where you can share your views and ask questions.
NOTE: PIPMG membership is required to join this session (but you can join PIPMG today for free!)
Meeting date: 1st October 2020 starting at: 11:00
Shola Ayeni, Applied Molecular Transport
Shola is a Senior Manager with 18 year experience in the Pharmaceutical and Biotechnology industry. She has led clinical trial projects particularly within rare and ultra rare diseases. Shola has held roles at Roche, GSK, Atlantic Healthcare and Regeneron
Prior to her role within Clinical operations Shola worked as a project Data Manager and took on the responsibility of delivering several database milestones.
Shola is passionate about creating mentoring opportunities for young graduates with an interest in the Pharmaceutical industry. She is enthusiastic about personal development and leadership.
Shola is a detailed oriented and proactive project manager with sound organisation skills, Shola enjoys public speaking and was previously President of Toastmaster international, a public speaking organisation.
1st Oct 2020
|11:10||Guest speaker||Shola Ayeni, Applied Molecular Transport|
|11:50||Breakout sessions||PIPMG Committee|
|12:15||Present Feedback from Breakout Sessions||PIPMG Committee|
The video meeting will be held on 1st Oct 2020, and will start at 11:00.